A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Conditions
Renal Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Alaska Oncology and Hematology ( Site 0133), Anchorage, Alaska, United States
Providence Medical Foundation ( Site 0141), Fullerton, California, United States
New England Cancer Specialists ( Site 0132), Westbrook, Maine, United States
Greater Baltimore Medical Center ( Site 0145), Baltimore, Maryland, United States
Metro-Minnesota Community Clinical Oncology ( Site 0144), Saint Louis Park, Minnesota, United States
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0131), Omaha, Nebraska, United States
Carolina Oncology Specialists, PA ( Site 9002), Charlotte, North Carolina, United States
Hospital Aleman ( Site 0204), CABA, Buenos Aires, Argentina
Hospital Italiano de Buenos Aires. ( Site 0203), Caba, Buenos Aires, Argentina
Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205), Caba, Buenos Aires, Argentina
Instituto Alexander Fleming ( Site 0202), CABA, Buenos Aires, Argentina
Hospital Universitario Austral ( Site 0212), Pilar, Buenos Aires, Argentina
Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0208), Caba., Buenos Aires F.D., Argentina
Sanatorio Parque ( Site 0201), Rosario, Santa Fe Province, Argentina
Instituto de Oncología de Rosario ( Site 0209), Rosario, Santa Fe Province, Argentina
Hospital Privado Universitario de Córdoba ( Site 0207), Córdoba, Argentina
Macquarie University-MQ Health Clinical Trials Unit ( Site 2100), Sydney, New South Wales, Australia
Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 0600), Linz, Upper Austria, Austria
Medizinische Universitat Wien ( Site 0601), Vienna, Austria
Cliniques Universitaires Saint-Luc ( Site 0703), Brussels, Bruxelles-Capitale, Region de, Belgium
Ziekenhuis Oost-Limburg, Campus St.-Jan ( Site 0701), Genk, Limburg, Belgium
UZ Gent ( Site 0702), Ghent, Oost-Vlaanderen, Belgium
UZ Leuven ( Site 0700), Leuven, Vlaams-Brabant, Belgium
IPC - MT Instituto de Pesquisas Clínicas do Mato Grosso ( Site 0305), Cuiabá, Mato Grosso, Brazil
Liga Norte Riograndense Contra o Câncer ( Site 0307), Natal, Rio Grande do Norte, Brazil
Hospital Moinhos de Vento ( Site 0309), Porto Alegre, Rio Grande do Sul, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0302), São José do Rio Preto, São Paulo, Brazil
Hospital Alemao Oswaldo Cruz ( Site 0311), São Paulo, São Paulo, Brazil
Klinički bolnički centar Sestre milosrdnice ( Site 0801), Zagreb, City of Zagreb, Croatia
Klinički bolnički centar Zagreb ( Site 0800), Zagreb, City of Zagreb, Croatia
Klinički Bolnički Centar Split ( Site 0802), Split, Split-Dalmatia County, Croatia
Masarykuv onkologicky ustav ( Site 0903), Brno, Brno-mesto, Czechia
Fakultni nemocnice Ostrava ( Site 0904), Ostrava, Ostrava Mesto, Czechia
Nemocnice České Budějovice ( Site 0905), České Budějovice, Czechia
Fakultni nemocnice Hradec Kralove ( Site 0902), Hradec Králové, Czechia
Fakultni nemocnice Olomouc ( Site 0901), Olomouc, Czechia
Vseobecna fakultni nemocnice v Praze ( Site 0906), Prague, Czechia
Fakultni nemocnice v Motole ( Site 0900), Prague, Czechia
Herlev Hospital ( Site 1002), Herlev, Capital Region, Denmark
Aarhus University Hospital Skejby ( Site 1001), Aarhus, Central Jutland, Denmark
Odense Universitetshospital ( Site 1000), Odense, Region Syddanmark, Denmark
CHU de Bordeaux Hop St ANDRE ( Site 1115), Bordeaux, Gironde, France
Hôpital Foch ( Site 1118), Suresnes, Hauts-de-Seine, France
Centre de Cancérologie du Grand Montpellier ( Site 1112), Montpellier, Herault, France
CHU GRENOBLE ALPES ( Site 1101), La Tronche, Isere, France
Centre d'Oncologie de Gentilly ( Site 1117), Nancy, Lorraine, France
Centre Hospitalier Universitaire d'Angers-Urology ( Site 1104), Angers, Pays de la Loire Region, France
Centre Hospitalier de la Cote Basque ( Site 1113), Bayonne, Pyrenees-Atlantiques, France
centre hospitalier lyon sud ( Site 1102), Pierre-Bénite, Rhone, France
CHU de Rouen ( Site 1108), Rouen, Seine-Maritime, France
HENRI MONDOR HOSPITAL ( Site 1116), Créteil, Val-de-Marne, France
CHD Vendee ( Site 1103), La Roche-sur-Yon, Vendee, France
Klinikum Stuttgart - Katharinenhospital ( Site 1201), Stuttgart, Baden-Wurttemberg, Germany
UniversitaetsklInikum Tuebingen ( Site 1207), Tübingen, Baden-Wurttemberg, Germany
Universitätsmedizin Göttingen - Georg-August-Universität ( Site 1211), Göttingen, Lower Saxony, Germany
Helios Kliniken Schwerin GmbH ( Site 1206), Schwerin, Mecklenburg-Vorpommern, Germany
Marienhospital Herne ( Site 1215), Herne, North Rhine-Westphalia, Germany
Universitaetsklinikum Muenster ( Site 1202), Münster, North Rhine-Westphalia, Germany
Universitaetsklinikum Carl Gustav Carus Dresden ( Site 1213), Dresden, Saxony, Germany
HELIOS Klinikum Erfurt ( Site 1208), Erfurt, Thuringia, Germany
Universitätsklinikum Jena ( Site 1204), Jena, Thuringia, Germany
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 1203), Berlin, Germany
Universitaetsklinikum Hamburg-Eppendorf ( Site 1214), Hamburg, Germany
Alexandra General Hospital of Athens ( Site 1300), Athens, Attica, Greece
Metropolitan Hospital ( Site 1302), Athens, Attica, Greece
University General Hospital ''Attikon'' - General Hospital of West Attica "H AGIA VARVARA" ( Site 1301), Chaïdári, Attica, Greece
Prince of Wales Hospital ( Site 2200), Hong Kong, Hong Kong
Queen Mary Hospital ( Site 2201), Hong Kong, Hong Kong
Cork University Hospital ( Site 1501), Cork, Ireland
Tallaght University Hospital ( Site 1500), Dublin, Ireland
Azienda Ospedaliera Di Rilievo Nazionale A. Cardarelli ( Site 1609), Naples, Campania, Italy
Istituto Nazionale Tumori Regina Elena ( Site 1611), Rome, Lazio, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1600), Milan, Milano, Italy
Istituto Clinico Humanitas ( Site 1613), Rozzano, Milano, Italy
Azienda Ospedaliera S. Luigi Gonzaga ( Site 1607), Orbassano, Piedmont, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1601), Rome, Roma, Italy
Azienda Ospedaliera Universitaria Careggi ( Site 1608), Florence, Tuscany, Italy
Istituto Oncologico Veneto IRCCS ( Site 1612), Castelfranco Veneto, Veneto, Italy
Casa di Cura Dott. Pederzoli - UO Oncologia ( Site 1610), Peschiera del Garda, Veneto, Italy
Azienda USL 8 di Arezzo ( Site 1605), Arezzo, Italy
A.O.U.C. Policlinico di Bari ( Site 1602), Bari, Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1604), Bologna, Italy
Ospedale San Martino ( Site 1606), Genova, Italy
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0503), Guadalajara, Jalisco, Mexico
I CAN ONCOLOGY CENTER S.A. DE C.V. ( Site 0507), Monterrey, Nuevo León, Mexico
Centro de Investigacion Clinica de Oaxaca ( Site 0502), Oaxaca City, Oaxaca, Mexico
Higiea Oncologia ( Site 0504), Mexico City, Mexico
Clinica Integral Internacional de Oncología ( Site 0506), Puebla City, Mexico
AIDPORT Sp. z o.o. ( Site 1716), Skórzewo, Greater Poland Voivodeship, Poland
Zakład Diagnostyki Laboratoryjnej, Centrum Onkologii ( Site 1707), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Pratia MCM Krakow ( Site 1713), Krakow, Lesser Poland Voivodeship, Poland
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 1703), Krakow, Lesser Poland Voivodeship, Poland
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1702), Siedlce, Masovian Voivodeship, Poland
MTZ Clinical Research Powered by Pratia ( Site 1705), Warsaw, Masovian Voivodeship, Poland
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1710), Przemyśl, Podkarpackie Voivodeship, Poland
Szpital Wojewodzki im. Mikolaja Kopernika w Koszalinie ( Site 1701), Koszalin, West Pomeranian Voivodeship, Poland
National University Hospital ( Site 2400), Singapore, Central Singapore, Singapore
National Cancer Centre Singapore ( Site 2401), Singapore, Central Singapore, Singapore
Chonnam National University Hwasun Hospital ( Site 2505), Hwasun-gun, Jeonranamdo, South Korea
Seoul National University Bundang Hospital ( Site 2504), Seongnam, Kyonggi-do, South Korea
Chungnam National University Hospital ( Site 2506), Taejŏn, Taejon-Kwangyokshi, South Korea
Severance Hospital, Yonsei University Health System ( Site 2503), Seoul, South Korea
Asan Medical Center ( Site 2501), Seoul, South Korea
Samsung Medical Center ( Site 2502), Seoul, South Korea
Institut Català d'Oncologia - L'Hospitalet ( Site 1805), L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario Marqués de Valdecilla ( Site 1807), Santander, Cantabria, Spain
Institut Català d'Oncologia (ICO) - Girona ( Site 1806), Girona, Gerona, Spain
Hospital Universitario Ramón y Cajal ( Site 1801), Madrid, Madrid, Comunidad de, Spain
Fundación Instituto Valenciano de Oncología ( Site 1808), Valencia, Valenciana, Comunitat, Spain
Hospital Universitari Vall d'Hebron ( Site 1804), Barcelona, Spain
Hospital Clinic de Barcelona ( Site 1810), Barcelona, Spain
Hospital Universitario Reina Sofia ( Site 1809), Córdoba, Spain
Hospital Clinico San Carlos ( Site 1802), Madrid, Spain
Hospital Universitario Fundacion Jimenez Diaz ( Site 1803), Madrid, Spain
Hospital Universitario 12 de Octubre ( Site 1800), Madrid, Spain
China Medical University Hospital ( Site 2603), Taichung, Taiwan
Taichung Veterans General Hospital ( Site 2602), Taichung, Taiwan
Taipei Veterans General Hospital ( Site 2600), Taipei, Taiwan
Chang Gung Memorial Hospital - Linkou Branch ( Site 2604), Taoyuan, Taiwan
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC